Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20194-20199

  Thai, To Ha ^a   Patterson, Heide Christine ^b,c,d,e   Pham, Duc Hung ^a,f   Kis Toth, Katalin ^a   Kaminski, Denise A ^g   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d LABORATORY FOR MOLECULAR MEDICINE   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

^g UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Erk pathways; SHIP 1

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MICRORNA 155;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE DELETION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84890284251     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317632110     Document Type: Article

References (47)

1. Thai TH, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316(5824):604-608.
2. Rodriguez A, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316(5824):608-611.
3. Vigorito E, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27(6):847-859.
4. Stagakis E, et al. (2011) Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 70(8):1496-1506.
5. Hao Z, et al. (2008) Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 29(4):615-627.
6. Pritchard NR, et al. (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10(4):227-230.
7. Jiang Y, et al. (1999) Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 11(10):1685-1691.
8. Jiang Y, et al. (2000) Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51(6):429-435.
9. Davis RS, Wang YH, Kubagawa H, Cooper MD (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 98(17):9772-9777.
10. Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD (2010) FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J Immunol 185(12):7405-7412.
11. Kochi Y, et al. (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 183(9):5502-5510.
12. Kochi Y, et al. (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37(5):478-485.
13. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275-290.
14. Isnardi I, Bruhns P, Bismuth G, Fridman WH, Daëron M (2006) The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation. Immunol Lett 104(1-2):156-165.
15. Tiller T, et al. (2010) Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice. J Exp Med 207(12):2767-2778.
16. Xiang Z, et al. (2007) FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8(4):419-429.
17. Condé C, Gloire G, Piette J (2011) Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer. Biochem Pharmacol 82(10):1320-1334.
18. Tamir I, Dal Porto JM, Cambier JC (2000) Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: Regulators of B cell signal transduction. Curr Opin Immunol 12(3):307-315.
19. Waterman PM, Cambier JC (2010) The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: Potential molecular mechanisms. FEBS Lett 584(24):4878-4882.
20. Vasudevan KM, Garraway LA (2010) AKT signaling in physiology and disease. Curr Top Microbiol Immunol 347:105-133.
21. Tamir I, et al. (2000) The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Immunity 12(3):347-358.
22. Mashima R, Hishida Y, Tezuka T, Yamanashi Y (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 232(1):273-285.
23. O'Neill SK, et al. (2011) Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35(5):746-756.
24. Helgason CD, et al. (2000) A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: Aberrant development and enhanced function of b lymphocytes in ship -/- mice. J Exp Med 191(5):781-794.
25. Helgason CD, et al. (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12(11):1610-1620.
26. Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277-285.
27. Liu Q, et al. (1998) The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 188(7):1333-1342.
28. Cremer TJ, et al. (2009) MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One 4(12):e8508.
29. Pedersen IM, et al. (2009) Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med 1(5):288-295.
30. Costinean S, et al. (2009) Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114(7):1374-1382.
31. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106(17):7113-7118.
32. Cohen PL, Eisenberg RA (1991) Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269.
33. Fortner KA, Lees RK, MacDonald HR, Budd RC (2011) Fas (CD95/APO-1) limits the expansion of T lymphocytes in an environment of limited T-cell antigen receptor/MHC contacts. Int Immunol 23(2):75-88.
34. Maldonado MA, et al. (1999) The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 162(11):6322-6330.
35. Satoh M, et al. (2007) Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 3(5):721-738.
36. Cohen-Solal J, Diamond B (2011) Lessons from an anti-DNA autoantibody. Mol Immunol 48(11):1328-1331.
37. William J, Euler C, Christensen S, Shlomchik MJ (2002) Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297(5589):2066-2070.
38. William J, Euler C, Shlomchik MJ (2005) Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: Differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J Immunol 174(11):6879-6887.
39. William J, Euler C, Leadbetter E, Marshak-Rothstein A, Shlomchik MJ (2005) Visualizing the onset and evolution of an autoantibody response in systemic autoimmunity. J Immunol 174(11):6872-6878.
40. Shlomchik M, et al. (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171(1):265-292.
41. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328(6133):805-811.
42. van Es JH, et al. (1991) Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 173(2):461-470.
43. Winkler TH, Fehr H, Kalden JR (1992) Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 22(7):1719-1728.
44. Wellmann U, et al. (2005) The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci USA 102(26):9258-9263.
45. Mietzner B, et al. (2008) Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA 105(28):9727-9732.
46. Racine R, et al. (2011) IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J Immunol 186(2):1011-1021.
47. Foote JB, Mahmoud TI, Vale AM, Kearney JF (2012) Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. J Immunol 188(1):57-67.